Literature DB >> 2830426

Ventricular pressure-heart rate product before induction of ischemia as a determinant of the reperfusion-induced accumulation of calcium within myocardium.

T Shiga1, M Nakazawa, S Imai.   

Abstract

Using the product of heart rate (HR) and left ventricular developed pressure (LVP) as a measure of the total mechanical energy required for contraction (TMEFC), experiments were performed with isolated perfused heart preparations of the guinea pig to establish the importance of TMEFC before induction of ischemia for induction of calcium accumulation within ischemic reperfused myocardium. Two calcium antagonists, diltiazem and nicardipine, and prazosin produced a dose-related suppression of the calcium accumulation when given prior to induction of ischemia (except for the highest dose of nicardipine), while they were ineffective when given only during the period of reperfusion, and the suppression was found to be closely correlated with the decrease in HRxLVP before induction of ischemia. The failure of the highest dose of nicardipine to suppress calcium accumulation (while producing a dose-related decrease in HRxLVP) was not associated with an increase in cyclic AMP. These findings are compatible with the idea that TMEFC before induction of ischemia is a prime determinant of calcium accumulation within the ischemic reperfused myocardium.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2830426     DOI: 10.1254/jjp.45.379

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  2 in total

1.  Degradation of sarcoplasmic reticulum calcium-pumping ATPase in ischemic-reperfused myocardium: role of calcium-activated neutral protease.

Authors:  Y Yoshida; T Shiga; S Imai
Journal:  Basic Res Cardiol       Date:  1990 Sep-Oct       Impact factor: 17.165

2.  Ischemic changes in myocardial ionic contents of the isolated perfused rat hearts as studied by NMR.

Authors:  T Ishibashi; M Nakazawa; S Imai
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.